Last Updated on June 22, 2023

Progress in Drug Research- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Birkhauser Verlag Basel




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

0.14

SJR

 0.189

h-Index

 44

Rank

 18578

Important Details

Title Progress in Drug Research
Type of Publication Book series
Discipline Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Molecular Medicine (Q4)
Impact Score 0.14
SCImago Journal Rank (SJR) 0.189
h-index 44
Overall Rank 18578
Publisher Name Birkhauser Verlag Basel
Publication Country Switzerland
International Standard Serial Number (ISSN) 0071786X
Coverage and History 1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-2018, 2021-2022
Best Quartile Q3
Total Citations Received
(Last 3 Year)
16

About Progress in Drug Research


Progress in Drug Research is a book series published by Birkhauser Verlag Basel. This book series covers the area[s] related to Medicine (miscellaneous), Pharmacology, Toxicology and Pharmaceutics (miscellaneous), Molecular Medicine, etc. The coverage history of this book series is as follows: 1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-2018, 2021-2022. The rank of this book series is 18578. This book series's impact score, h-index, and SJR are 0.14, 44, and 0.189, respectively. The ISSN of this book series is/are as follows: 0071786X.

The best quartile of Progress in Drug Research is Q3. This book series has received a total of 16 citations during the last three years (Preceding 2018).


Progress in Drug Research Impact Score 2018-2019


The latest impact score (IS) of the Progress in Drug Research is 0.14. It is computed in the year 2019 as per its definition and based on Scopus data.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting


Impact Score Graph


Check below the Impact Score trends of Progress in Drug Research. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2018 0.14
2017 0.34
2016 3.77
2015 2.70
2014 0.00

Progress in Drug Research h-index


  Table Setting

The h-index of Progress in Drug Research is 44. By definition of the h-index, this book series has at least 44 published articles with more than 44 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Progress in Drug Research ISSN


The International Standard Serial Number (ISSN) of Progress in Drug Research is/are as follows: 0071786X.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Progress in Drug Research Ranking and SCImago Journal Rank (SJR)


The Progress in Drug Research is ranked 18578 among 27955 Journals, Conferences, and Book Series. As per SJR, this book series is ranked 0.189.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Progress in Drug Research Publisher


Table Setting

The publisher of Progress in Drug Research is Birkhauser Verlag Basel. The publishing house of this book series is located in the Switzerland. Its coverage history is as follows: 1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-2018, 2021-2022.


Call For Papers (CFPs)


Please check the official website of this book series to find out the complete details and Call For Papers (CFPs).


How to publish in Progress in Drug Research


If your area of research or discipline is related to Medicine (miscellaneous), Pharmacology, Toxicology and Pharmaceutics (miscellaneous), Molecular Medicine, etc., please check the book series's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Progress in Drug Research?

The latest impact score of Progress in Drug Research is 0.14. It is computed in the year 2019.


What is the h-index of Progress in Drug Research?

The latest h-index of Progress in Drug Research is 44. It is evaluated in the year 2019.


What is the SCImago Journal Rank (SJR) of Progress in Drug Research?

The latest SCImago Journal Rank (SJR) of Progress in Drug Research is 0.189. It is calculated in the year 2019.


What is the ranking of Progress in Drug Research?

The latest ranking of Progress in Drug Research is 18578. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2019.


Who is the publisher of Progress in Drug Research?

Progress in Drug Research is published by Birkhauser Verlag Basel. The publication country of this book series is Switzerland.


What is the abbreviation of Progress in Drug Research?

This standard abbreviation of Progress in Drug Research is .


Is "Progress in Drug Research" a Journal, Conference or Book Series?

Progress in Drug Research is a book series published by Birkhauser Verlag Basel.


What is the scope of Progress in Drug Research?

The scope of Progress in Drug Research is as follows:

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Molecular Medicine

For detailed scope of Progress in Drug Research, check the official website of this book series.


What is the ISSN of Progress in Drug Research?

The International Standard Serial Number (ISSN) of Progress in Drug Research is/are as follows: 0071786X.


What is the best quartile for Progress in Drug Research?

The best quartile for Progress in Drug Research is Q3.


What is the coverage history of Progress in Drug Research?

The coverage history of Progress in Drug Research is as follows 1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-2018, 2021-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Air and Space Power Journal (discontinued) Journal AU Press 28397 9 0.20
Journal of Classical Sociology Journal SAGE Publications Ltd 13766 27 0.83
Journal of Sociolinguistics Journal Wiley-Blackwell Publishing Ltd 5409 61 1.96
Studies in Continuing Education Journal Routledge 6011 38 2.81
Palaeontographica Abteilung B: Palaeophytologie Book Series E. Schweizerbart'sche Verlagsbuchhandlung 15138 16 2.20
Acta Periodica Technologica Journal University of Novi Sad, Faculty of Technology 19470 18 0.62
Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining Conference And Proceedings 4334 192 0.00
Brazilian Symposium of Computer Graphic and Image Processing Conference And Proceedings 16004 32 0.00
Communications in Computational Physics Journal Global Science Press 3847 64 2.63
PLoS ONE Journal Public Library of Science 5108 404 3.75

Check complete list




Progress in Drug Research Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2019/2020 Updated Soon
2018 0.14
2017 0.34
2016 3.77
2015 2.70
2014 0.00



Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Nature Reviews Disease Primers
Nature Publishing Group | United Kingdom

Current Protocols in Bioinformatics
John Wiley & Sons Inc. | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Annual Review of Public Health
Annual Reviews Inc. | United States

Nature Reviews Methods Primers
Springer Nature | United States

See All

Top Journals/Conferences in Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Acta Pharmaceutica Sinica B
Elsevier BV | Netherlands

Theranostics
Ivyspring International Publisher | Australia

PLoS Neglected Tropical Diseases
Public Library of Science | United States

Current Protocols
John Wiley & Sons Inc. | United States

Life Sciences
Elsevier Inc. | United States

Clinical and Translational Science
Wiley-Blackwell Publishing Ltd | United Kingdom

Drug Metabolism Reviews
Informa Healthcare | United States

Nanotheranostics
Ivyspring International Publishers | Australia

Expert Review of Clinical Pharmacology
Taylor and Francis Ltd. | United Kingdom

F1000Research
| United Kingdom

Marine Drugs
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

American Journal of Pharmaceutical Education
American Association of Colleges of Pharmacy | United States

Antibiotics
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

Journal of Zhejiang University: Science B
Zhejiang University Press | China

Journal of Cardiovascular Development and Disease
MDPI AG | Switzerland

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

Trends in Molecular Medicine
Elsevier Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Biomarker Research
BioMed Central Ltd. | United Kingdom

Cellular and Molecular Life Sciences
Birkhauser Verlag Basel | Switzerland

See All